Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
Phase 1
Completed
- Conditions
- Breast NeoplasmsMetastases, Neoplasm
- Interventions
- First Posted Date
- 2002-05-20
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT00037609
- Locations
- 🇺🇸
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Clofarabine in Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- Hematologic NeoplasmsLymphoproliferative DisordersLeukemiaLeukemia, Lymphocytic, Chronic
- First Posted Date
- 2002-01-09
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT00028418
- Locations
- 🇺🇸
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath